| Literature DB >> 21943053 |
David J Irwin1, Robert J Schwartzman.
Abstract
Patients with complex regional pain syndrome (CRPS) often suffer from an array of associated movement disorders, including dystonia of an affected limb. We present a case of a patient with long standing CRPS after a brachial plexus injury, who after displaying several features of the movement disorder previously, developed painful dystonia of chest wall musculature. Detailed neurologic examination found palpable sustained contractions of the pectoral and intercostal muscles in addition to surface allodynia. Needle electromyography of the intercostal and paraspinal muscles supported the diagnosis of dystonia. In addition, pulmonary function testing showed both restrictive and obstructive features in the absence of a clear cardiopulmonary etiology. Treatment was initiated with intrathecal baclofen and the patient had symptomatic relief and improvement of dystonia. This case illustrates a novel form of the movement disorder associated with CRPS with response to intrathecal baclofen treatment.Entities:
Year: 2011 PMID: 21943053 PMCID: PMC3189858 DOI: 10.1186/1749-7221-6-6
Source DB: PubMed Journal: J Brachial Plex Peripher Nerve Inj ISSN: 1749-7221
Pulmonary function testing results before and after intrathecal baclofen treatment
| FVC | FEV1 | FEF 25-75% | PEF | TLC | RV | DLCO | |
|---|---|---|---|---|---|---|---|
| 1.83 L (44% Ref) | 1.60 L (49% Ref) | 2.20 L/sec (73% Ref) | 5.34 L/sec (71% Ref) | 2.71 L (45% Ref) | 0.88 L (40% Ref) | 12.20 mL/mmHg/min (44% Ref) | |
| 2.06 L (50% Ref) | 1.78 L (54% Ref) | 2.44 L/sec (81% Ref) | 4.62 L/sec (62% Ref) | NA | NA | NA | |
| 1.95 L (47% Ref) | 1.57 L (49% Ref) | 1.59 L/sec (53% Ref) | 4.74 L/sec (64% Ref) | 3.07 L (52% Ref) | 1.10 L (50% Ref) | 11.00 mL/mmHg/min (36% Ref) | |
| 2.18 L (53% Ref) | 1.79 L (55% Ref) | 1.97 L/sec (66% Ref) | 4.89 L/sec (66% Ref) | NA | NA | NA |
† Patient intrathecal medication dose at time of study: Baclofen 0 μg/day, Dilaudid 26.5 mg/day
†† Patient intrathecal medication dose at time of study: Baclofen 400 μg/day, Dilaudid 21.5 mg/day